Product Reports Resources Pricing Login Book a demo

KoBioLabs

Biotech & Life Sciences · Seoul, South Korea · Founded 2014

Engaged in patents and studies in various fields including microbiome analysis, probiotics, and microbiome treatment technology MoreLess

KoBioLabs operates in the biotechnology sector, focusing on the development of microbiome-based products that promote beneficial interactions between the human body and the environment. The company serves a diverse range of clients, including healthcare providers, environmental organizations, and consumers seeking health and wellness solutions. KoBioLabs leverages its expertise in microbiomes to create products that improve health outcomes and environmental sustainability. The business model revolves around research and development, product sales, and strategic partnerships. Revenue is generated through the sale of proprietary microbiome products and solutions, as well as through collaborations and licensing agreements. KoBioLabs is committed to providing a supportive environment for its employees, fostering creativity and passion, and ensuring high returns on investment for its stakeholders.

Keywords: biotechnology, microbiome, health, environment, sustainability, R&D, partnerships, innovation, wellness, proprietary products.

Talent graph

KoBioLabs's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on KoBioLabs's cap table

Sourced from Dealroom's funding and investor records.

Series B+ 1 investor entered at this stage
E-mart

Global footprint

Where KoBioLabs has talent and traffic

Workforce by country
2 countries with
team presence
🇰🇷 South Korea90.9%
🇸🇬 Singapore9.1%
2 countries shown

Market sentiment

What the market is saying about KoBioLabs

An AI-synthesized read of the highest-engagement posts about KoBioLabs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See KoBioLabs on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.